Study protocol

(16954510), Douglas H. Fernald; (16954513), Donald E. Nease Jr.; (10955511), John M. Westfall; (7921289), Bethany M. Kwan; (8852369), L. Miriam Dickinson; (16954516), Ben Sofie; (6868019), Cory Lutgen; (13770173), Jennifer K. Carroll; (3506819), David Wolff; (16954519), Lori Heeren; (16954522), Maret Felzien; (16954525), Linda Zittleman

doi:10.1371/journal.pone.0290388.s002

Public

Study protocol.

Published in Figshare • Sep 8, 2023

NobleIDNI7P77W70R21S55

Authors:

Douglas H. Fernald (16954510)

,

Donald E. Nease Jr. (16954513)

,

John M. Westfall (10955511)

Abstract

<div><p>Opioid use disorder (OUD) represents a public health crisis in the United States. Medication for opioid use disorder (MOUD) with buprenorphine in primary care is a proven OUD treatment strategy. MOUD induction is when patients begin withdrawal and receive the first doses of buprenorphine. Di...

Subject

Buprenorphine

Opioid use disorder

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!